Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis

American Journal of Hematology

Volumn 87, Issue 6, 2012, Pages 637-639

  Nishi, Masanori ^a   Nishimura, Ryosei ^b   Suzuki, Nobuhiro ^c   Sawada, Akihisa ^d   Okamura, Takayuki ^e   Fujita, Naoto ^f   Kanai, Rie ^g   Yano, Jun ^h   Adachi, Souichi ⁱ   Yasumi, Takahiro ⁱ   Sato, Emiko ^j   Yasutomo, Koji ^k   Ishii, Eiichi ^l   Ohga, Shouichi ^m  

^a SAGA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^e UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^f ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^g SHIMANE UNIVERSITY HOSPITAL   (Japan)

^h SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

ⁱ KYOTO UNIVERSITY HOSPITAL   (Japan)

^j OSAKA UNIVERSITY HOSPITAL   (Japan)

^k UNIVERSITY OF TOKUSHIMA   (Japan)

^l EHIME UNIVERSITY HOSPITAL   (Japan)

^m KYUSHU UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; MELPHALAN;

CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHIMERA; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFANT; LETTER; LIVER FAILURE; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHOLE BODY RADIATION;

BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MELPHALAN; REOPERATION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 84861339937     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23190     Document Type: Letter

References (20)

1. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: Clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010; 6: 137-154.
2. Cetica V, Pende D, Griffiths GM, Aricò M. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica 2010; 95: 538-541.
3. Johnson TS, Villanueva J, Filipovich AH, et al. Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. J Immunol Methods 2011; 364: 1-13.
4. Dürken M, Horstmann M, Bieling P, et al. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients. Br J Haematol 1999; 106: 1052-1058.
5. Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
6. Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622-630.
7. Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: A single-center report of 48 patients. Pediatrics 2006; 117: e743-e750.
8. Baker KS, Filipovich AH, Gross TG, et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008; 42: 175-180.
9. Cesaro S, Locatelli F, Lanino E, et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: A retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Haematologica 2008; 93: 1694-1701.
10. Yoon HS, Im HJ, Moon HN, et al. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Pediatr Transplant 2010; 14: 735-740.
11. Ohga S, Kudo K, Ishii E, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010; 54: 299-306.
12. Cooper N, Rao K, Gilmour K, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 2006; 107: 1233-1236.
13. Marsh RA, Vaughn G, Kim MO, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010; 116: 5824-5831.
14. Ohta H, Miyashita E, Hirata I, et al. Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis. Int J Hematol 2011; 94: 285-290.
15. Marsh RA, Jordan MB, Filipovich AH. Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: An important step forward. Br J Haematol 2011; 154: 556-563.
16. Takanashi M, Tanaka H, Kohsaki M, et al. A suggested total size for the cord blood banks of Japan. Bone Marrow Transplant 2011; 46: 1014-1015.
17. Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874-2880.
18. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
19. Suga N, Takada H, Nomura A, et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol 2002; 116: 346-349.
20. Murata Y, Yasumi T, Shirakawa R, et al. Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc13-4 protein. Blood 2011; 118: 1225-1230.